Biostate 71,500 36,500 108,000 7 855 * The total in this table combines the values for patients with mild, moderate and severe conditions. The severity of a patient’s condition is not always known at initial presentation. This table includes product issues to patients with unknown/not specified treatment regimens. All products listed above are in IUs unless stated. **IUs sums all the products except NovoSeven 24 - IU HMA HMB Haemophilia A Haemophilia B Severity Regimen type Total IUs Number of patients Total IUs Number of patients On demand 3,535,050 182 1,453,000 45 Adult - Mild Prophylaxis 560,000 6 72,000 <5 On demand 5,780,000 68 2,310,500 41 Adult - Moderate Prophylaxis 6,928,500 26 3,824,000 13 Tolerisation 120,000 <5 On demand 19,227,250 102 4,598,000 24 Adult - Severe Prophylaxis 69,014,325 241 6,863,000 26 Tolerisation 1,421,000 <5 447,000 <5 Adult - Total 106,586,125 <635 19,567,500 <159 On demand 339,250 43 130,750 11 Paediatric - Mild Prophylaxis 639,250 6 189,500 <5 On demand 392,750 35 397,500 9 Paediatric - Moderate Prophylaxis 4,218,000 25 996,750 7 On demand 410,493 24 85,750 6 Paediatric - Severe Prophylaxis 39,586,750 224 4,574,750 33 Tolerisation 3,448,250 14 Paediatric - Total 49,034,743 371 6,375,000 <71 * Values in this table exclude products issued to patients with unknown severity classification or treatment regimen, so they will vary from those figures shown previously. **Patients may receive more than one regimen type and may therefore be counted multiple times.
Biostate 71,500 36,500 108,000 7 855 * The total in this table combines the values for patients with mild, moderate and severe conditions. The severity of a patient’s condition is not always known at initial presentation. This table includes product issues to patients with unknown/not specified treatment regimens. All products listed above are in IUs unless stated. **IUs sums all the products except NovoSeven 24 - IU HMA HMB Haemophilia A Haemophilia B Severity Regimen type Total IUs Number of patients Total IUs Number of patients Adult - Mild On demand 3,535,050 182 1,453,000 45 Prophylaxis 560,000 6 72,000 <5 Adult - Moderate On demand 5,780,000 68 2,310,500 41 Prophylaxis 6,928,500 26 3,824,000 13 Tolerisation 120,000 <5 Adult - Severe On demand 19,227,250 102 4,598,000 24 Prophylaxis 69,014,325 241 6,863,000 26 Tolerisation 1,421,000 <5 447,000 <5 Adult - Total 106,586,125 <635 19,567,500 <159 Paediatric - Mild On demand 339,250 43 130,750 11 Prophylaxis 639,250 6 189,500 <5 Paediatric - Moderate On demand 392,750 35 397,500 9 Prophylaxis 4,218,000 25 996,750 7 Paediatric - Severe On demand 410,493 24 85,750 6 Prophylaxis 39,586,750 224 4,574,750 33 Tolerisation 3,448,250 14 Paediatric - Total 49,034,743 371 6,375,000 <71 * Values in this table exclude products issued to patients with unknown severity classification or treatment regimen, so they will vary from those figures shown previously. **Patients may receive more than one regimen type and may therefore be counted multiple times.
abdr-annual-report-2015-16-final.docx